3D Printed Oncology Prosthetics Market

Segmentation By Material (Polypropylene, Polyurethane, Acrylics and Polyethylene and Others); By End Users (Medical & Surgical Centers, Pharma & Biotech Companies, Academic Institutions, Hospitals, Rehabilitation Centers and Others) – Global Demand Analysis & Opportunity Outlook 2027

Buy Now
Report ID: 1537 | Published On: Feb 02, 2023
Request Free Sample Copy

Growth Drivers

Increasing Number of Cancer Cases

Cancer has a major impact on the society across the world. The most common cancers are breast cancer, lungs cancer, liver cancer, bone cancer and many others. According to National Cancer Institute, in 2018, around 17 lakh new cases were diagnosed in the U.S. and around 6 lakh people died due to the disease. These statistics shows that there would be rise in the number of cases in the near future which is further expected to boost the market growth during the forecast period.

Prosthetics According to Patient Need

The 3D printing technology has the benefit of designing the prosthetics according to the patient’s anatomy which makes the design more precise and real, furthering the growth of the market growth during the forecast period.


Lack of Awareness

There is lack of awareness among people regarding various technological advancements that have been made in the treatment of cancers using prosthetics of various types, which is expected to restrain the growth of the market during the forecast period.

High Cost

The cancer treatment is not affordable by most of the population as the cost associated with it is very high. This is expected to hinder the growth of the market.

3D Printed oncology Prosthetics market Graph
Get more information on this report: Request Sample PDF

Market Size and Forecast

3D printed tumor models help the doctors and surgeons to get the better understanding of the cancer cells they are going to treat or remove from the patient’s body. It can also help the patients understand their own body conditions. This technology helps the doctors know more about cancer and how different types of cancer respond to different treatments. Additionally, 3D printed oncology prosthetics can be used for experimental and new cancer treatments and gives the scientists a better idea about how the drug works for different cancers in humans. These factors are estimated to propel the market growth in the near future.

The global 3D printed oncology prosthetics market is anticipated to grow at a significant CAGR over the forecast period i.e. 2019-2027. The market is segmented by material & end users. The material segment is further bifurcated into polypropylene, polyurethane, acrylics and polyethylene, and others, out of which, the polypropylene and polyethylene material segment is anticipated to have significant growth on account of their wide usability in the designing of the 3D printed prosthetic implants for various tumors. Both the segments are expected to collectively gain advantage and market share during the forecast period. 

On the basis of end users, the market is divided into medical & surgical centers, pharma & biotech companies, academic institutions, hospitals, rehabilitation centers and others, out of which, the hospital segment is anticipated to have significant growth on account of large number of patients approaching hospitals and availability of wide range of specialty treatments. The initiatives by the leading players in the market in order to make collaborations between the hospitals and rehabilitation centers is expected to contribute to the growth of the 3D printed oncology prosthetics market.

New applications in 3D printing are now being used in the medical field. Researchers are focusing on developing printers that can print human tissue and even pills. Additionally, new technological advancements in the market such as the invention of 3D printed cancer cells for the treatment of cancer which involves taking a sample of cells, growing a tumor to test on and then finding the best treatment for the patient to make the treatment patient specific is anticipated to boost the growth of the market. The technique has been widely used in the treatment of breast cancer. In the near future, patients would be able to print their drugs at home with the help of this technology.

Market Segmentation

Our-in depth analysis of the global 3D printed oncology prosthetics market includes the following segments:

By Material

  • Polypropylene
  • Polyurethane
  • Acrylics
  • Polyethylene
  • Others

By End Users

  • Medical & Surgical Centers
  • Pharma & Biotech Companies
  • Academic Institutions
  • Hospitals
  • Rehabilitation Centers
  • Others

By Region

On the basis of regional analysis, the global 3D printed oncology prosthetics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region

The market in North America is anticipated to have largest share in 3D printed oncology prosthetics market owing to the rise in the incidences of cancer cases and growing number of accidental injuries in the region. The market in Asia Pacific region is expected to witness significant growth where India and Australia hold the markets with major growth in the region on account of rising awareness among people about the technological advancements pertaining to 3D printed oncology prosthetics. The market in Middle East and Africa and Latin America region are estimated to witness relatively slow growth attributed to lack of awareness among the patients.

3D Printed oncology Prosthetics market Graph

Get more information on this report: Download Sample PDF

The global 3D printed oncology prosthetics market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • GE Healthcare 
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
    • Xilloc Medical B.V.
    • Neusoft Medical System
    • Koninklijke Philips N.V
    • Siemens Healthineers
    • 3D Life Prints Limited
    • Canon Inc.

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample